Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Capital Gains tax rules effective 2024 CRA

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Jun 22, 2023 1:24pm

178 Views

Post# 35509554

RE:RE:RE:New Capital Gains tax rules effective 2024 CRA

I have as much as my TFSA will allow and have maxed out kids TFSA's as well. :) I am reasonably confident the proposed changes to the AMT will not be affected by capital gains realized in TFSA's or RRSP's. Only will affect non-registered accounts and properties.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs